The Medtronic MiniMed 770G System is the first FDA approved hybrid closed loop system that monitors glucose and automatically adjusts the delivery of long acting or basal insulin based on the user’s glucose reading in users two years and up. Smart Guard Auto Mode automatically adjusts insulin delivery. It helps predict highs and lows in advance and increases or decreases insulin delivery. Now with smartphone connectivity.
- Monitor your glucose levels 24/7 and predict whether you’re going high or low.
- Smooth out highs and lows, with Smart Guard
- Auto Mode that increases or decreases insulin delivery, every 5 minutes.
- Continuously adapts to your needs based on your real-time data and personal trends.
- View, share, and automatically upload your insulin and continuous glucose monitor (CGM) data directly from your smartphone.